Indian Pharma Legal & Regulatory Intelligence
A unified India-focused intelligence system covering pharmaceutical laws, rules, regulatory developments, judgments, compliance, enforcement and legal alerts.
Six Core Intelligence Sections
Independent modules • Individually editableIndian Pharma Laws
Acts and primary pharmaceutical legislation governing the Indian pharmaceutical sector.
Rules & Regulations
Indian pharmaceutical rules, schedules, requirements and regulatory provisions.
Regulatory Notifications
Indian regulatory notifications, amendments, circulars and important regulatory changes.
Court Judgments & Legal Opinions
Indian pharmaceutical-related judgments, legal opinions, interpretations and important precedents.
Compliance & Enforcement
Pharmaceutical compliance requirements, inspections, violations, enforcement actions and recalls.
Legal / Regulatory Alerts
Important Indian pharmaceutical legal and regulatory developments requiring attention.
The six sections are independent modules. Their content can be created, edited, replaced, updated or removed separately. This master dashboard contains no WordPress page links and does not require modification when an individual section is updated.
Pharma Legal, Enforcement & Alert Intelligence
Source-linked judgments, compliance and enforcement developments, and regulatory alerts.
Court Judgments & Legal Opinions
Pharma-related cases, judgments, legal opinions and precedents.
148 recordsOpen Section →02
Compliance & Enforcement
Compliance requirements, inspections, violations, enforcement actions and recalls.
27 recordsOpen Section →03
Legal / Regulatory Alerts
Important legal and regulatory developments requiring attention.
503 recordsOpen Section →
Compliance & Enforcement · 27 visible records
Recent official updates
Fixed-dose combination restriction for children below four years
Summary: The Central Government restricted the specified fixed-dose combination for use in children below four years.
Outcome / action: Manufacturers and sellers must observe the notified age restriction and associated labelling requirements.
Practical impact: Review formulations, labels, prescribing information and distribution controls.
Open official source →Medical Devices Rules: Rule 63 and Class A quality-management requirements
Summary: A notified amendment updates regulatory requirements connected with Rule 63 and quality-management compliance for Class A devices.
Outcome / action: The amended device-compliance framework applies according to the notification.
Practical impact: Device firms should check licensing, QMS and implementation obligations.
Open official source →Medical-device sterilization and labelling requirements updated
Summary: The Ninth Schedule requirements relating to sterilization and labelling were amended.
Outcome / action: Affected device labels and sterilization controls must align with the amended schedule.
Practical impact: Review packaging, validation records and release procedures.
Open official source →Form 29 test-licence categories amended
Summary: The notified amendment revises categories and requirements associated with Form 29 test licences.
Outcome / action: Applications and internal test-manufacture controls must use the amended framework.
Practical impact: Update regulatory submissions and test-batch procedures.
Open official source →Karnataka NSQ alert: Ringer Lactate batch KI056158
Summary: The state authority listed the identified Ringer Lactate batch in its not-of-standard-quality information.
Outcome / action: Supply-chain participants should verify the official notice and isolate affected stock where applicable.
Practical impact: Check batch inventory, distribution records and escalation procedures.
Open official source →Maharashtra product recall: Rectin Plus
Summary: The Maharashtra authority published recall information concerning Rectin Plus.
Outcome / action: Affected parties should verify product and batch details against the official recall record.
Practical impact: Review inventory, customer notifications and recall effectiveness.
Open official source →Paracetamol Tablets IP 650 mg (Acetamol 650)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →Betnipro (Betamethasone Sodium Phosphate Tablets IP 0.5 mg)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup (Frezcold AM COUGH SYRUP)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →Sytop-D (Pantoprazole & Domperidone Tablets)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →3
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →Nimcef (Cefixime and Lactic Acid Bacillus Tablets)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →AMI-COXUM LB (Amoxycillin, Cloxacillin & Lactic Acid Bacillus Capsules)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →IRRION (Ferrous Ascorbate & Folic Acid Tablets IP)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →Ketoconazole 1% Medicated Soap (DR ZIP)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →TICSOP Medicated Soap (veterinary)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →Meloxicam, Paracetamol & Serratiopeptidase Bolus (ZOBID MPS)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →Paracetamol Tablets I. P. 650 mg (Paragee-650)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →PUBLIC ALERT COMPOUND SODIUM LACTATE INJECTION IP 500 ML (RINGER’S LACTATE)
Summary: Automatically discovered on an official Central or State drug-regulatory source. Verify the linked authority record.
Outcome / action: Official-source item discovered automatically.
Practical impact: Review the linked record before compliance or publication action.
Open source record →SODIUM CHLORIDE INJECTION IP (0.9% W/V) (NS)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →Order for Immediate Recall of Allopathic Drugs- Rectin Plus Tablets
Summary: Automatically discovered on an official Central or State drug-regulatory source. Verify the linked authority record.
Outcome / action: Official-source item discovered automatically.
Practical impact: Review the linked record before compliance or publication action.
Open source record →COMPOUND SODIUM LACTATE INJECTION IP (RINGER-LACTATE SOLUTION FOR INJECTION) RL
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →Substandard Drugs
Summary: Automatically discovered on an official Central or State drug-regulatory source. Verify the linked authority record.
Outcome / action: Official-source item discovered automatically.
Practical impact: Review the linked record before compliance or publication action.
Open source record →NSQ Alerts (Not of Standard Quality)
Summary: Automatically discovered on an official Central or State drug-regulatory source. Verify the linked authority record.
Outcome / action: Official-source item discovered automatically.
Practical impact: Review the linked record before compliance or publication action.
Open source record →PAROX-MR TABLETS (Etoricoxib &Thiocolchicoside Tablets)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →CDSCO Drug Quality, NSQ and Spurious Drug Alerts
Summary: Official CDSCO compilation of central and state drug alerts, Not of Standard Quality results, spurious/adulterated/misbranded product notices and other safety-related alerts.
Outcome / action: Continuously updated official source directory; open the source to view the latest published authority records.
Practical impact: Use the latest dated CDSCO document to identify the product, batch, manufacturer, test result and authority before taking compliance or publication action.
Open official source →